Moreover, probiotics and prebiotics can improve the immunological aspect by upregulating anti-inflammatory markers such as IL-10 and TGF-β, while reducing the production of proinflammatory cytokines such as TNF-α in the intestinal mucosa of IBD patients (76). Here, TGFB1 is linked to inflammatory bowel disease.